IDEAYA Biosciences Inc.

NASDAQ: IDYA · Real-Time Price · USD
24.33
-0.04 (-0.16%)
At close: Aug 15, 2025, 3:59 PM
24.33
0.00%
After-hours: Aug 15, 2025, 04:54 PM EDT

IDEAYA Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-331.8M -307.08M -274.48M -178.12M -153.74M -128.89M -112.96M -103.21M -74.15M -68.28M -58.66M -52.67M -65.86M -54.75M -49.76M -36.69M -30.03M -31.47M
Depreciation & Amortization
4.02M 3.88M 3.83M 4.21M 4.23M 4.13M 4.01M 2.49M 2.39M 2.6M 2.1M 3.04M 2.57M 1.81M 1.73M 1.64M 1.53M 1.43M
Stock-Based Compensation
40.8M 38.67M 34.75M 30.06M 26.14M 21.14M 18.49M 16.67M 14.37M 12.68M 11.63M 10.72M 9.91M 8.92M 8.24M 7.22M 6M 4.77M
Other Working Capital
2.13M 9.64M 3.25M -1.43M -4.49M -13.91M -16.04M -15.97M -40.61M -40.98M -44.31M -42.1M -24.04M -27.66M -23.54M -28.85M 72.29M 77.1M
Other Non-Cash Items
-7.9M -18.48M -12.09M 26.78M 28.58M 30.45M 26.28M -8.8M -5.32M -2.6M -695K 102K -10.83M -10.56M -10.45M -14.85M -3.7M -4.12M
Deferred Income Tax
n/a n/a n/a -37.83M -37.83M -37.83M -37.83M n/a n/a n/a n/a 799K 12.29M 12.29M 12.29M 16.62M 5.13M 5.13M
Change in Working Capital
1.17M 21.11M 11.55M 16.36M 13.14M -11.26M -13.21M -21.99M -46.12M -39.77M -41.55M -42.46M -16.83M -19.41M -17.81M -24.66M 73.02M 75.55M
Operating Cash Flow
-293.7M -264.11M -247.58M -149.68M -130.62M -131.19M -115.22M -114.85M -108.84M -95.37M -87.17M -80.46M -68.76M -61.7M -55.78M -50.72M 51.96M 51.28M
Capital Expenditures
-3.55M -3.86M -3.86M -3.59M -3.74M -3.65M -2.37M -1.53M -2.03M -3.08M -3.44M -4.05M -3.4M -2.04M -2.64M -2.22M -2M -1.5M
Cash Acquisitions
n/a n/a n/a 111.11M 59.16M 179.65M 156.09M 44.98M 114.52M -21.24M 2.33M 2.33M -15.26M n/a n/a -18K -18K -18K
Purchase of Investments
-783.52M -820.74M -1.19B -1.08B -943.98M -999.47M -595.98M -439.88M -446.13M -263.8M -255.81M -222.88M -284.17M -340.56M -315M -310.33M -349.11M -269.8M
Sales Maturities Of Investments
695.67M 755.83M 692.61M 662.07M 601.71M 467.17M 439.89M 384.62M 321.34M 274.77M 225.85M 203.38M 226.41M 218.74M 247.97M 238.74M 150.04M 150.58M
Other Investing Acitivies
n/a 69.53M -283.12M -394.22M -342.27M -532.3M -156.09M -55.26M -124.79M 10.96M -29.96M -19.49M -57.76M -121.82M -67.02M -67.2M -194.69M -114.83M
Investing Cash Flow
-91.41M -68.77M -502.56M -417.39M -346.01M -535.95M -158.46M -56.79M -126.82M 7.88M -33.4M -23.54M -61.16M -123.86M -69.67M -73.81M -201.08M -120.71M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a -66K -75K -75K -75K -9K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
16.96M 18.59M 22.92M 33.64M 23.65M 58.05M 52.95M 39.8M 38.09M 1.33M 1.61M 1.98M 2.64M 2.72M 2.18M 1.86M 1.34M 1.59M
Financial Cash Flow
316.61M 354.58M 677.55M 815.69M 557.02M 708.9M 362.72M 222.15M 290.01M 99.44M 97.17M 97.53M 88.61M 104.1M 145.45M 151.72M 92.01M 170.72M
Net Cash Flow
-67.6M 22.46M -71.83M 250.1M 80.96M 42.48M 89.76M 50.51M 54.35M 11.95M -23.41M -6.47M -41.32M -81.46M 20.01M 27.19M -57.12M 101.29M
Free Cash Flow
-297.26M -267.98M -251.44M -153.27M -134.36M -134.84M -117.59M -116.38M -110.87M -98.45M -90.62M -84.51M -72.17M -63.74M -58.42M -52.94M 49.95M 49.79M